Stock & Company Details
Collegium Pharmaceutical Inc $COLL
Price:
N/A
N/A
33M
$720M
52 Week High:
N/A
10 Day Average Volume:
N/A
19.84
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
COLL technical indicators
Latest Collegium Pharmaceutical Inc (COLL) indicator readings as of 2026-10-09.
COLL's 14-day RSI is 33.8, in neutral territory. At $22.09 it is trading 37.0% below its 200-day moving average of $35.07, and below its 50-day average of $25.37. Price sits in the middle of its Bollinger Bands ($21.53 to $23.05). ADX reads 37.8, indicating a trending market.
Overview
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.
Finance Bot
Ask your questions
Start by typing a question below.
